Company: OSRH
Filing Date: 2025-01-24
Form Type: S-4/A
Source: 0001213900-25-006139
Chunk: 324

Company: OSR Holdings, Inc.
Filing Date: 2025-01-24
Form: S-4/A
Chunk 324
---
 be exchanged for shares of BLAC Common Stock at Closing, and such Company Common Stock will be subject to the Put Right and Call Right set forth in the Non -ParticipatingStockholder Joinder. Consideration The consideration paid to the OSR Holdings at Closing will be BLAC Common Stock. BLAC will receive OSR Holdings Common Stock in connection with the Share Exchange. Representation and Warranties Under the Business Combination Agreement, BLAC made customary representations and warranties relating to, among other things: •the organization and qualification of BLAC, including BLAC being duly organized, validly existing and in good standing under applicable laws and having requisite corporate or other organizational power and authority and all necessary governmental approvals to carry on its business; •the capitalization of BLAC, including the authorized and outstanding capital stock of BLAC, and a representation that there are no undisclosed derivative securities, commitments, agreements or arrangements relating to the issued or unissued capital stock of BLAC; •BLAC’s authority, including BLAC’s power and authority to perform its obligations under the Business Combination Agreement and to consummate the transactions contemplated thereby; •non -contravention, including a representation that the execution and delivery of the Business Combination Agreement by BLAC does not require any consent, approval, authorization or permit of, or filing with or notification to, any Governmental Authority (except for, if any, exchange act, blue sky law, and similar securities and state law requirements), or (i) conflict with or violate the organizational documents of BLAC, (ii) conflict with or violate any law, (iii) result in any breach of or constitute a default pursuant to any agreement, except with respect to clauses (ii) and (iii), such conflicts or breaches which do not constitute a BLAC Material Adverse Effect; 195 •compliance with laws and material agreements; •SEC reports and financial statements, including with respect to (i) the timely filing of all required forms, reports, schedules, statements and other documents, (ii) compliance with securities laws and applicable listing rules and regulations, and (iii) appropriate disclosure controls and procedures (in each case except as and to the extent set forth in BLAC’s SEC filings); •the absence of certain changes or events that would constitute a BLAC Material Adverse Effect; •the absence of litigation, including a representation that there is no action pending or threatened against BLAC before any governmental authority; •BLAC Board and BLAC M&A Committee approval of the Business Combination Agreement and the